Adecoagro S.A. (AGRO) 11.13 $AGRO Adecoagro recorded

New Post Public Reply Private Reply Replies (0) Message Board

Jun 13, 2016 at 8:11 PM

Adecoagro S.A. (AGRO) 11.13 $AGRO

Adecoagro recorded 1Q16 Adjusted EBITDA of $43.2 million, 113% higher year-over-year, and EBITDA margin of 37%
PR Newswire - Thu May 12, 4:02PM CDT
Adecoagro S.A. (NYSE: AGRO, Bloomberg: AGRO US, Reuters: AGRO.K), one of the leading agricultural companies in South America, announced today its results for the first quarter of 2016.
AGRO: 11.13 (-0.05)

Adecoagro announces filing of annual report on form 20-F for year ended December 31, 2015 on April 27, 2016
PR Newswire - Wed May 04, 2:42PM CDT
Adecoagro S.A. ("Adecoagro"

(NYSE: AGRO) one of the leading agricultural companies in South America, announced today the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2015 on April 27, 2016. The Form 20-F is available on Adecoagro's website at http://ir.adecoagro.com. Adecoagro will provide its shareholders, upon request and free of charge, a hard copy of our Form 20-F, including our audited consolidated financial statements as of and for the fiscal year ended December 31, 2015.
AGRO: 11.13 (-0.05)

Adecoagro Announces Pricing of Secondary Offering by Selling Shareholders
PR Newswire - Tue Mar 22, 7:00AM CDT
Adecoagro SA (NYSE: AGRO), one of the leading agricultural companies in South America, announced today the pricing of an underwritten secondary offering of 12,000,000 common shares offered by Quantum Partners LP and Geosor Corporation at a price per share to the public of $11.70. The selling shareholders have granted the underwriter the right to purchase up to 1,800,000 additional common shares. The underwriter can exercise this right once at any time within 30 days after March 21, 2016.
AGRO: 11.13 (-0.05)

Adecoagro Announces Offering of its Common Shares by Certain Selling Shareholders
PR Newswire - Mon Mar 21, 3:15PM CDT
Adecoagro S.A. (NYSE: AGRO), one of the leading agricultural companies in South America, announced today that it has commenced a public offering of 12,000,000 of its common shares to be sold by certain selling shareholders, subject to market and other conditions. Morgan Stanley & Co. LLC will act as sole bookrunner for the offering. The selling shareholders have granted the underwriter the right to purchase up to 1,800,000 additional common shares. The underwriter can exercise this right once at any time within 30 days after March 21, 2016. Adecoagro will not receive any of the proceeds from the sale by the selling shareholders of the common shares in this offering.
AGRO: 11.13 (-0.05), MS: 25.26 (-0.28)

Adecoagro posts 4Q profit
Automated Insights - Thu Mar 17, 6:45PM CDT
LUXEMBOURG (AP) _ Adecoagro SA (AGRO) on Thursday reported fourth-quarter net income of $446,000, after reporting a loss in the same period a year earlier.
AGRO: 11.13 (-0.05)

Adecoagro recorded Adjusted EBITDA of $78.1 million in 4Q15, 107.1% higher year-over-year, driving 2015 Adjusted EBITDA to $203.1 million
PR Newswire - Thu Mar 17, 4:22PM CDT
Adecoagro S.A. (NYSE: AGRO, Bloomberg: AGRO US, Reuters: AGRO.K), one of the leading agricultural companies in South America, announced today its results for the fourth quarter of 2015.
AGRO: 11.13 (-0.05)

Archer Daniels to Fuel Growth with Moroccan Facility Buyout
Zacks Equity Research - Zacks Investment Research - Tue Feb 09, 1:50PM CST
Archer Daniels' (ADM) acquisition of the Moroccan corn wet mill, which manufactures glucose and local starch, is expected to close in the first half of 2016.
ADM: 41.82 (-1.21), CAG: 46.47 (-0.48), PF: 43.37 (-0.61), AGRO: 11.13 (-0.05)

Should You Get Rid of Archer-Daniels-Midland (ADM) Now?
Zacks Equity Research - Zacks Investment Research - Wed Nov 18, 7:32AM CST
Archer-Daniels-Midland is a stock to drop as it has witnessed negative trend in earnings estimate revisions and has seen its price decline significantly.
ADM: 41.82 (-1.21), AGRO: 11.13 (-0.05)

3 Reasons Momentum Stock Investors Will Love Adecoagro (AGRO)
Zacks Equity Research - Zacks Investment Research - Tue Nov 17, 7:53AM CST
Adecoagro is a great momentum stock and has been witnessing positive activity in the earnings estimate revision front as well
AGRO: 11.13 (-0.05)

Company News for November 16, 2015
Zacks Equity Research - Zacks Investment Research - Mon Nov 16, 9:10AM CST
Companies in the News are: FOSL,YUM,AGRO,AMAT
FOSL: 26.87 (-1.18), AMAT: 23.94 (-0.13), AGRO: 11.13 (-0.05), YUM: 82.57 (+0.07)

Adecoagro recorded an Adjusted EBITDA of $49.7 million in 3Q15 and $124.9 million in 9M15
PR Newswire - Thu Nov 12, 4:09PM CST
Adecoagro S.A. (NYSE: AGRO, Bloomberg: AGRO US, Reuters: AGRO.K), one of the leading agricultural companies in South America, announced today its results for the third quarter of 2015.
AGRO: 11.13 (-0.05)

Amira Foods (ANFI) Surges on Clearing Independent Review
Zacks Equity Research - Zacks Investment Research - Thu Nov 12, 11:50AM CST
Shares of Amira Foods (ANFI) soared yesterday.
DMND: 37.56 (+0.36), CRESY: 13.44 (-0.21), AGRO: 11.13 (-0.05), ANFI: 7.16 (-0.17)

Strength Seen in Adecoagro S.A. (AGRO): Stock Adds 7.2%
Zacks Equity Research - Zacks Investment Research - Tue Oct 27, 7:25AM CDT
Adecoagro S.A. (AGRO) saw its shares rise over 7% on the day.
CRESY: 13.44 (-0.21), AGRO: 11.13 (-0.05)

New Strong Buy Stocks for October 22nd
Zacks Equity Research - Zacks Investment Research - Thu Oct 22, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
ACHC: 59.71 (-1.84), AMSF: 63.01 (-1.49), ABG: 54.10 (-0.32), ALLY: 17.03 (-0.51), AGRO: 11.13 (-0.05)

BUYINS.NET: AGRO SqueezeTrigger Price is $8.99. There is $2,582,100 That Short Sellers Still Need To Cover.
M2 - Thu Oct 15, 11:54AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring Adecoagro SA (NYSE:AGRO) in real time and just received an alert that AGRO is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 286900 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $8.99. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
AGRO: 11.13 (-0.05)

New Strong Buy Stocks for October 14th
Zacks Equity Research - Zacks Investment Research - Wed Oct 14, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
FFG: 60.75 (-1.34), GHM: 18.05 (-0.37), AHT: 5.19 (-0.03), AGRO: 11.13 (-0.05), MTG: 6.23 (-0.18)

BUYINS.NET: AGRO SqueezeTrigger Price is $8.99. There is $2,616,528 That Short Sellers Still Need To Cover.
M2 - Wed Oct 07, 12:00PM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring Adecoagro SA (NYSE:AGRO) in real time and just received an alert that AGRO is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 286900 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $8.99. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
AGRO: 11.13 (-0.05)

iRobot (IRBT) Tops Q2 Earnings, Maintains Yearly Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 22, 7:47AM CDT
iRobot Corporation (IRBT) reported better-than-expected results for second-quarter 2015, reflecting year-over-year growth in revenues.
CLX: 131.18 (-0.59), AGRO: 11.13 (-0.05), IRBT: 37.17 (-0.45), ROK: 115.94 (-0.76)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

RYBREVANT's Promising Results in HNSCC Treatment

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Tennessee's Bold Lung Cancer Trial Signals Innovation

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Gildan Activewear Faces Legal Battle Over Alleged Fraud

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Miranda Lambert Lights Up Red Kettle Campaign

By Logan Wright Updated Oct 25, 2026 Category News Views 227

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Community in Shock After Fatal Bakersfield Shooting

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

BAIC FOTON Eyes African Market with Strategic Moves

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...